A patient receiving immunotherapy with pembrolizumab develops a new onset dry cough and dyspnea at rest. The nurse should suspect:
-
A
Hospital-acquired pneumonia
-
B
Immune-mediated pneumonitis
-
C
Pulmonary embolism from prolonged immobility
-
D
Pleural effusion from disease progression